Curigliano G - Search Results

1

A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, with or without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer.

Jhaveri K, Juric D, Yap YS, Cresta S, Layman RM, Duhoux FP, Terret C, Takahashi S, Huober J, Kundamal N, Sheng Q, Balbin A, Ji Y, He W, Crystal A, De Vita S, Curigliano G. Jhaveri K, et al. Among authors: curigliano g. Clin Cancer Res. 2021 Nov 1;27(21):5760-5770. doi: 10.1158/1078-0432.CCR-21-1095. Epub 2021 Aug 25. Clin Cancer Res. 2021. PMID: 34433648 Free PMC article.

2

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors.

Colleoni M, Minchella I, Mazzarol G, Nolè F, Peruzzotti G, Rocca A, Viale G, Orlando L, Ferretti G, Curigliano G, Veronesi P, Intra M, Goldhirsch A. Colleoni M, et al. Among authors: curigliano g. Ann Oncol. 2000 Aug;11(8):1057-9. doi: 10.1023/a:1008334404825. Ann Oncol. 2000. PMID: 11038046 Free article.

3

Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features.

Curigliano G, Rigo R, Colleoni M, Braud FD, Nole F, Formica V, Orlando L, Cinieri S, Torrisi R, Cardillo A, Peruzzotti G, Medici M, Ardito R, Minchella I, Goldhirsch A. Curigliano G, et al. Clin Breast Cancer. 2004 Jun;5(2):125-30. doi: 10.3816/cbc.2004.n.016. Clin Breast Cancer. 2004. PMID: 15245616 Review.

4

Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients.

Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, Nolè F, de Braud F, Orlando L, Leonardi MC, Galimberti V, Intra M, Veronesi P, Renne G, Cinieri S, Audisio RA, Luini A, Orecchia R, Viale G, Goldhirsch A. Gennari R, et al. Among authors: curigliano g. Cancer. 2004 Sep 15;101(6):1302-10. doi: 10.1002/cncr.20535. Cancer. 2004. PMID: 15316944 Free article.

5

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.

Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, Gelber RD, Curigliano G, Torrisi R, Luini A, Intra M, Galimberti V, Renne G, Nolè F, Peruzzotti G, Goldhirsch A. Colleoni M, et al. Among authors: curigliano g. Clin Cancer Res. 2004 Oct 1;10(19):6622-8. doi: 10.1158/1078-0432.CCR-04-0380. Clin Cancer Res. 2004. PMID: 15475452 Free article.

6

Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare.

De Pas T, Pelosi G, de Braud F, Veronesi G, Curigliano G, Leon ME, Danesi R, Noberasco C, d'Aiuto M, Catalano G, Viale G, Spaggiari L. De Pas T, et al. Among authors: curigliano g. J Clin Oncol. 2004 Dec 15;22(24):4966-70. doi: 10.1200/JCO.2004.01.195. J Clin Oncol. 2004. PMID: 15611511 Free article.

7

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy.

Munzone E, Curigliano G, Rocca A, Bonizzi G, Renne G, Goldhirsch A, Nolè F. Munzone E, et al. Among authors: curigliano g. Breast Cancer Res. 2006;8(1):R4. doi: 10.1186/bcr1366. Epub 2005 Dec 7. Breast Cancer Res. 2006. PMID: 16417653 Free PMC article. Clinical Trial.

8

Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer.

Spitaleri G, Matei DV, Curigliano G, Detti S, Verweij F, Zambito S, Scardino E, Rocco B, Nolè F, Ariu L, De Pas T, de Braud F, De Cobelli O. Spitaleri G, et al. Among authors: curigliano g. Ann Oncol. 2009 Mar;20(3):498-502. doi: 10.1093/annonc/mdn650. Epub 2009 Jan 12. Ann Oncol. 2009. PMID: 19139180 Free article. Clinical Trial.

9

Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer.

Curigliano G, Viale G, Bagnardi V, Fumagalli L, Locatelli M, Rotmensz N, Ghisini R, Colleoni M, Munzone E, Veronesi P, Zurrida S, Nolè F, Goldhirsch A. Curigliano G, et al. J Clin Oncol. 2009 Dec 1;27(34):5693-9. doi: 10.1200/JCO.2009.22.0962. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884553

10

Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: a systematic review of randomized controlled trials.

Brollo J, Curigliano G, Disalvatore D, Marrone BF, Criscitiello C, Bagnardi V, Kneubil MC, Fumagalli L, Locatelli M, Manunta S, Goldhirsch A. Brollo J, et al. Among authors: curigliano g. Cancer Treat Rev. 2013 Feb;39(1):44-50. doi: 10.1016/j.ctrv.2012.03.009. Epub 2012 Apr 27. Cancer Treat Rev. 2013. PMID: 22541668 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page